top
Search terms
Results 1 - 6 of 6 - ordered by :
Escardio

Existing antithrombotic therapy during and after PCI consists of the mandatory use of aspirin, intravenous (IV) anticoagulation (such as unfractionated heparin, low molecular weight heparin, or ...

Date : 28/08/2017
Escardio

EMBARGO : 31 August 2015 at 14:15 BST The ATLANTIC2 study showed that the potent P2Y12 antagonist ticagrelor given in the ambulance (pre-hospital) in patients with ST-segment elevation myocardial ...

Date : 31/08/2015
Escardio

MRAs, also known as aldosterone antagonists, inhibit sodium retention and excretion of potassium and magnesium, and therefore “there is an indication for MRA therapy in MI patients with heart ...

Date : 30/08/2015
Escardio

Ambulance administration of the antiplatelet medication ticagrelor to patients with a type of heart attack known as ST segment elevation myocardial infarction (STEMI) is not better than hospital ...

Date : 01/09/2014
Escardio

A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial ...

Date : 30/04/2014
Escardio

Revascularisation strategies for unprotected left main coronary disease: results from a GRACE registry study - PCI and CABG appear to provide complementary treatment options in ULMCD ...

Date : 31/08/2009